Population
Wildtype, Fgf2 knockout, non-transgenic, and FGF2 transgenic mice
Comparison
Isoproterenol via subcutaneous mini-osmotic pump… vs Saline via subcutaneous mini-osmotic pump implants
Design
Preclinical
Authors
Loading...
FGF2-ERK inhibition may mitigate stress-induced hypertrophy; leaves open clinical translation beyond rodent models.
FGF2 mediates isoproterenol-induced cardiac hypertrophy and maladaptive dysfunction through the activation of the ERK signaling pathway.
House et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: